ID: ALA148585

Max Phase: Preclinical

Molecular Formula: C12H15N7O

Molecular Weight: 273.30

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  OCc1nccc(N2CCN(c3ncncn3)CC2)n1

Standard InChI:  InChI=1S/C12H15N7O/c20-7-10-14-2-1-11(17-10)18-3-5-19(6-4-18)12-15-8-13-9-16-12/h1-2,8-9,20H,3-7H2

Standard InChI Key:  DRBDDIHHJRKHCT-UHFFFAOYSA-N

Associated Targets(Human)

Sorbitol dehydrogenase 133 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 273.30Molecular Weight (Monoisotopic): 273.1338AlogP: -0.52#Rotatable Bonds: 3
Polar Surface Area: 91.16Molecular Species: NEUTRALHBA: 8HBD: 1
#RO5 Violations: 0HBA (Lipinski): 8HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 13.55CX Basic pKa: 4.84CX LogP: 0.73CX LogD: 0.73
Aromatic Rings: 2Heavy Atoms: 20QED Weighted: 0.80Np Likeness Score: -1.28

References

1. Chu-Moyer MY, Ballinger WE, Beebe DA, Berger R, Coutcher JB, Day WW, Li J, Mylari BL, Oates PJ, Weekly RM..  (2002)  Orally-effective, long-acting sorbitol dehydrogenase inhibitors: synthesis, structure-activity relationships, and in vivo evaluations of novel heterocycle-substituted piperazino-pyrimidines.,  45  (2): [PMID:11784155] [10.1021/jm010440g]

Source